Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Crysvita“
Suchtreffer
Begriffe & Kennungen
Crysvita · 4.8 · Adverse reactions in paediatric patients with TIO No data are available in paediatric patients with TIO (see s
Eintrag öffnenCrysvita · 4.8 · Hyperphosphataemia Adult patients with XLH or TIO: In XLH patients, in the placebo-controlled treatment period
Eintrag öffnenCrysvita · 4.8 · Hypersensitivity Paediatric patients with XLH: Hypersensitivity reactions (e.g.: injection site reactions, ras
Eintrag öffnenCrysvita · 4.8 · Immunogenicity: Paediatric patients with XLH: Overall, the incidence of anti-drug antibodies (ADA) to burosuma
Eintrag öffnenCrysvita · 4.8 · Injection site pain, Injection site rash, Injection site bruising, Injection site discolouration, Injection si
Eintrag öffnenCrysvita · 4.8 · Injection site pain, Injection site rash, Injection site bruising, Injection site discolouration, Injection si
Eintrag öffnenCrysvita · 4.8 · Injection site reactions Paediatric patients with XLH: Local reactions (e.g. injection site urticaria, erythem
Eintrag öffnenCrysvita · 4.8 · MedDRA System Organ Class Frequency Category Adverse Reaction Infections and infestations Very common Tooth in
Eintrag öffnenCrysvita · 4.8 · MedDRA System Organ Class Frequency category Adverse reaction Infections and infestations Very common Tooth ab
Eintrag öffnenCrysvita · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenCrysvita · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenCrysvita · 4.8 · Restless legs syndrome Adult patients with XLH or TIO: In XLH patients, in the placebo-controlled treatment pe
Eintrag öffnenCrysvita · 4.8 · Summary of the safety profile
Eintrag öffnenCrysvita · 4.8 · Tabulated lists of adverse reactions The frequencies of adverse reactions are listed in Table 1 (XLH, paediatr
Eintrag öffnenCrysvita · 4.8 · The adverse reactions are presented by system organ class and frequency categories, defined using the followin
Eintrag öffnenCrysvita · 4.8 · The most common (> 10%) adverse drug reactions reported during clinical trials in adult patients with XLH or a
Eintrag öffnenCrysvita · 4.8 · The most common (> 10%) adverse drug reactions reported in paediatric patients with XLH during clinical trials
Eintrag öffnenCrysvita · 4.8 · Vitamin D Decreased Paediatric patients with XLH: Reduced serum 25 hydroxy-vitamin D has been observed followi
Eintrag öffnen